Barinthus Biotherapeutics (BRNS) Net Cash Flow (QoQ) (2020 - 2026)
Barinthus Biotherapeutics (BRNS) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Barinthus Biotherapeutics | 27.57 Mn | -39.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.91% |
| Dec 31, 2025 | 58.73% |
| Sep 30, 2025 | 43.36% |
| Jun 30, 2025 | -21.71% |
| Mar 31, 2025 | -209.23% |
| Dec 31, 2024 | 176.46% |
| Sep 30, 2024 | -50.73% |
| Jun 30, 2024 | -1.83% |
| Mar 31, 2024 | 39.88% |
| Dec 31, 2023 | -72.98% |
| Sep 30, 2023 | 43.96% |
| Jun 30, 2023 | -399.80% |
| Mar 31, 2023 | 65.12% |
| Dec 31, 2022 | -216.00% |
| Sep 30, 2022 | 194.44% |
| Jun 30, 2022 | -33.42% |
| Mar 31, 2022 | 61.15% |
| Dec 31, 2021 | -470.42% |
| Sep 30, 2021 | -104.04% |
| Jun 30, 2021 | -22.89% |